国际医学：公司非公开发行股票符合公司发展战略

Core Viewpoint - The company has confirmed that its non-public stock issuance aligns with its development strategy and has received necessary approvals from the board, shareholders, and regulatory authorities [2] Group 1 - The non-public stock issuance is intended to support the company's business development and enhance its operational capabilities [2] - The fundraising through non-public issuance is seen as beneficial for the long-term development of the company and the interests of all shareholders [2]